Adocia strengthens its cash position by 19 million euros following a real estate transaction – 03/28/2022 at 18:16


(AOF) – Adocia, a clinical-stage biopharmaceutical company, has announced the completion of the sale of its laboratory and office complex, located in Lyon, France, to a specialized investor. This financial transaction resulted in the sale of the building for an amount of more than 20 million euros and the signing of a long-term lease. At the same time as the sale, the two parties signed a lease agreement allowing Adocia to continue to occupy the building for the long term.

The lease is for a firm term of 12 years, with an option to renew for another nine years.

“Thanks to this real estate transaction, we have 19 million euros in additional cash while reducing our debt. This is being done without significant additional operating costs and without any impact on operations and the work of the teams”, declared Valérie Danaguezian, Financial Director of Adocia.

Following this operation, the rent owed by the company will be of a similar amount and will replace the reimbursement of the debts which had been contracted in order to finance the purchase of the building in 2016, these debts having been fully reimbursed, today, in as part of the sale transaction.

AOF – LEARN MORE

Boost for French pharmacy

At the end of a recent CSIS, the French authorities announced an amount of credits (7 billion euros) never reached: 1.5 billion for hospital-university research, 2 billion for investment in health via bpi france , 1.5 billion in aid for the relocation of industrial projects, and 2 billion to strengthen investment in three sectors of the future (bioproduction, digital medicine, and pandemic preparedness). In addition, the annual growth in drug expenditure reimbursed by Medicare will be 2.4%, which should generate growth of at least 0.5% in the turnover of laboratories,

Above all, the normal drug marketing procedure will be accelerated (up to 500 days saved) if the medical benefit rendered is sufficient.



Source link -86